Göran Bertilsson

Title: **Göran Bertilsson: Innovator in Angiogenesis Research**

Introduction

Göran Bertilsson is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of medicinal research, particularly concerning angiogenesis and tumor progression. With two patents to his name, his work is paving the way for new treatment methodologies.

Latest Patents

Göran's latest patents revolve around the use of a mammalian polypeptide known as Inhibitory PAS Domain Protein (IPAS). This polypeptide is crucial for inhibiting angiogenesis and preventing tumor progression. His inventions encompass screening methods to identify compounds that may serve as effective medicaments for medical conditions associated with angiogenesis or tumor progression. This cutting-edge research offers hope in the realm of cancer treatment.

Career Highlights

Göran is currently associated with Angiogenetics Sweden AB, where he continues his research into the mechanisms of angiogenesis and its implications for various diseases. His dedication to advancing medicinal science has positioned him as a key figure in his field.

Collaborations

Throughout his career, Göran has collaborated with notable professionals such as Anders Berkenstam and Lorenz Poellinger. These partnerships have fostered a conducive environment for innovation and have expanded the reach and impact of his research.

Conclusion

In summary, Göran Bertilsson stands out as an influential inventor in the study of angiogenesis and tumor progression. His innovative patents and collaborative efforts underline his commitment to enhancing medical treatments, making him a valuable asset to the scientific community.